Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View

Nucleix Ltd

http://nucleix.com

Latest From Nucleix Ltd

Scrip Asks…What Does 2023 Hold For Biopharma? Part 8: Therapeutic Area Advances

Bookmark
  • Analysis
By Eleanor Malone

Neuroscience and oncology fuel high hopes for therapeutic R&D progress among 90-plus surveyed biopharma industry leaders.

Scrip Asks Research & Development

Orange County Entrepreneur Banks On Data-Based Approach To Detect, Treat Diseases

Bookmark
  • News
By Marion Webb

IV BioHoldings CEO Marty Keiser connects data, technology, capital and people to create start-ups focusing on liquid biopsy programs.

Launches Diagnostics

Nucleix Adds $55M To Support EpiCheck Lung Cancer Test

Bookmark
By Reed Miller

The new money will help the company advance its unique EpiCheck technology for detecting cancer-specific-changes to DNA called methylation.

Financing Cancer
See All

Company Information

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By